{
    "organizations": [],
    "uuid": "bcb61793d9d8e046acb2f0da29d396fb4c8df5a8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-strides-shasun-to-launch-ranitidin/brief-strides-shasun-to-launch-ranitidine-otc-tablets-in-u-s-idUSFWN1QF01N",
    "ord_in_thread": 0,
    "title": "BRIEF-Strides Shasun To Launch Ranitidine OTC Tablets In U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Strides Shasun Ltd:\n* TO LAUNCH RANITIDINE OTC TABLETS IN THE US MARKETS * PRODUCT WILL BE MANUFACTURED AT THE JV'S (COMPANY'S 50:50 JV WITH VIVIMED LABS) ORAL DOSAGE FACILITY IN CHENNAI‍​ Source text: bit.ly/2oqiNHS Further company coverage:\n ",
    "published": "2018-02-26T12:06:00.000+02:00",
    "crawled": "2018-02-26T16:57:54.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "stride",
        "shasun",
        "ltd",
        "launch",
        "ranitidine",
        "otc",
        "tablet",
        "u",
        "market",
        "product",
        "manufactured",
        "jv",
        "company",
        "jv",
        "vivimed",
        "lab",
        "oral",
        "dosage",
        "facility",
        "source",
        "text",
        "company",
        "coverage"
    ]
}